InnovaRx Innova Health Strategies

G71.0349

Limb girdle muscular dystrophy due to other sarcoglycan dysfunction

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 11 never code together
G71code
Excludes2
  • arthrogryposis multiplex congenita (Q74.3)Q74.3
  • metabolic disorders (E70-E88)E70-E88
  • myositis (M60.-)M60.-
G00-G99chapter
Excludes2
  • certain conditions originating in the perinatal period (P04-P96)P04-P96
  • certain infectious and parasitic diseases (A00-B99)A00-B99
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
  • congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)Q00-Q99
  • endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
  • injury, poisoning and certain other consequences of external causes (S00-T88)S00-T88
  • neoplasms (C00-D49)C00-D49
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 6
Inclusion terms
  • Delta sarcoglycanopathy
  • Delta-sarcoglycan-related LGMD R6
  • Gamma sarcoglycanopathy
  • Gamma-sarcoglycan-related LGMD R5
  • Limb girdle muscular dystrophy type 2C
  • Limb girdle muscular dystrophy type 2F
Index entries leading here 2
Alongside this code 3 same parent — G71.034
Medications 1

MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.

Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC76 CMS28HCC197 ESRD21HCC76 ESRD24HCC76

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
G71.034
Block
G70-G73
Siblings
3

Present FY2024–FY2027.